Table: Kringle Pharma - 6-MTH parent results

Kringle Pharma

12/05/2025 07:40

May 12 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Mar 31, 2025        Mar 31, 2024       Sep 30, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            35 mln              43 mln            272 mln     
                 (-16.5 pct)         (+25.3 pct)       (+239.8 pct)  
  Operating     loss 511 mln        loss 366 mln        loss 1.38    
  Recurring     loss 511 mln        loss 365 mln        loss 1.38    
  Net           loss 512 mln        loss 366 mln        loss 1.38    
  EPS          loss 75.15 yen      loss 60.21 yen    loss 202.18 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T